Synonyms: Singulair®
montelukast is an approved drug (FDA (1998))
Compound class:
Synthetic organic
Comment: Montelukast is a leukotriene receptor antagonist (LTRA), with selectivity for cysteinyl leukotriene receptor 1 (CysLT1 receptor).
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: montelukast |
|
Immunopharmacology Comments |
As an anti-asthma drug montelukast antagonises the action of leukotriene D4 at the CysLT1 receptor in the airway. |
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Asthma |
Disease Ontology:
DOID:2841 OMIM: 600807 |
Leukotriene receptor antagonist approved for the treatment of asthma. |